Table 3.
Haplotypic frequencies of three SNP pairs compared between the PF patient and the endemic control groups.
Haplotype | PF (%) | Control (%) | OR | 95% CI | P |
---|---|---|---|---|---|
CD1D | |||||
rs16839951, rs422236 | |||||
AG | 232 (49.8) | 186 (49.5) | 1.01 | 0.77 – 1.33 | 0.945 |
GT | 32 (6.9) | 30 (8.0) | 0.85 | 0.51 – 1.43 | 0.596 |
AT | 202 (43.3) | 160 (42.5) | 1.03 | 0.78 – 1.36 | 0.834 |
KLRG1, KLRD1 | |||||
rs1805672, rs2537752 | |||||
GA | 74 (14.6) | 45 (12.0) | 1.25 | 0.84 – 1.86 | 0.275 |
AA | 175 (34.6) | 130 (34.8) | 0.99 | 0.75 – 1.31 | 1.000 |
GT | 71 (14.0) | 51 (13.6) | 1.03 | 0.70 – 1.52 | 0.921 |
AT | 186 (36.7) | 148 (39.6) | 0.89 | 0.67 – 1.17 | 0.400 |
TNFSF13B | |||||
rs116898958, rs4145212 | |||||
TA | 10 (2.1) | 7 (1.8) | 1.16 | 0.44 – 3.07 | 0.810 |
CA | 101 (21.5) | 86 (22.6) | 0.94 | 0.67 – 1.29 | 0.739 |
CT | 359 (76.4) | 286 (75.3) | 1.16 | 0.43 – 3.10 | 0.809 |
OR: odds ratio. CI: confidence interval. P: two-tailed P value.